Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Major Shareholding Notification 2008

Feb 3, 2008

65124_rns_2008-02-03_a3e91bd2-0b20-412b-9114-2b47dd5fc69c.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

603 page 1/2

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial holder

To: Imugene Limited ACN 009 179 551

1. Details of substantial holder (1)

Name Dr Warwick Andrew Lamb

ACN/ARSN (if applicable) n/a

The holder became a substantial holder on 31/01/08

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

C lass of securities (4) lass of securities (4) N umber of securities Person's votes (5) Voting power (6)
O rdinary Shares 7,520,002 7,520,002 5.2%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

H older of relevant interest Nature of relevant interest (7) Class and number of securities
H ELD DIRECTLY RegisteredHolder 7,245,002Ordinary Shares
VETSPECPTY LTD RegisteredHolder 275,000 Ordinary Shares

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant Registered holder of Class and number of
interest securities Person entitled to be registered as holder (8) securities
Dr Warwick Andrew Dr Warwick Andrew
Lamb Lamb Dr Warwick Andrew Lamb 7,245,002Ordinary Shares
VETSPECPTY LTD VETSPECPTY LTD VETSPECPTY LTD 275,000 Ordinary Shares

603 page 2/2

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

5. Consideration 5. Consideration
The consideration paid for each relev ant interest referred to in paragraph 3 abo ve, and acquired in the four months prior to
that the substantial holder became a s ubstantial holder is as follows:
Holder ofrelevantinterest Date of acquisition Consideration (9) Classnumbsecur ander ofities
Cash N on-cash
23 January2008 $86,100 n/a 615,001 Fullypaid ordinaryshares
23 January2008 $3,500 n/a 25,000 Fullypaid ordinaryshares
31January2008 $67,200 n/a 480,000 Fullypaid ordinaryshares

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if
applicable) Nature of association
VETSPECPTY LTD ControlledBody Corporate

7. Addresses

The addresses of persons named in this form are as follows:

Name Address
Dr Warwick Andrew Lamb Level 1,14-20Delhi Road,NORTH RYDE NSW 2113
VetspecPtyLtd Level 1,14-20Delhi Road,NORTH RYDE NSW 2113

Signature

print Registered holder and name Warwick Lamb capacity Director sign date 4 / 2 / 08 here